Stifel reiterates Buy on Ligand Pharma stock, $332 target — See source for full details.
$LGND
Price history, market instrument context, member research, and related headlines in one place.
LGND key statistics
NasdaqGMUSD
52-week range
$175.8979%$326.63
Latest session $292.64–$297.67Ligand Pharmaceuticals Incorporated (LGND) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $295.54, down $2.96 (0.99%) from the previous close of $298.50. It has traded between $292.64 and $297.67 in the latest session. Over the past year it has ranged from $175.89 to $326.63, leaving it in the upper quarter of its 52-week range (79%). Reported volume for the session was 164.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
WOOK AIASK ANYTHING · NEVER ADVISES
Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.
Source-linked intelligence
Related news
Oppenheimer raises Ligand Pharma stock price target to $326 — See source for full details.
Loading $LGND research…